摘要:
The present invention relates to compounds of the general formula (I) and salts, prodrugs, and stereoisomers thereof, wherein Y independently represents S, O, NR2, SO, SO2; A independently represents a fife- or six-membered aromatic carbocycle or heterocycle and wherein R1 to R20 in formula (I) represent independently of each other a variety of different substituents comprising alkyl, aryl, aralkyl, alkylaryl, heteroaryl groups and monofunctional moieties.
摘要:
The present invention relates to compounds of the general formula (I), and the pharmaceutically acceptable salt or solvate thereof, as anti-inflammatory and immunomodulatory agents.
摘要:
The present invention relates to compounds of the general formula (I), and the pharmaceutically acceptable salt or solvate thereof, as anti-inflammatory and immunomodulatory agents.
摘要:
The invention relates to new diphenylurea having the formula (I) or a salt thereof, where Y is C═O, C═S, C═NH, (C═O)2 or SO2; and to processes for the preparation of these compounds and to their use in the treatment of protozoal diseases and to diseases where the inhibition of intracellular protein-degradation pathways is of benefit.
摘要:
The present invention relates to the use of compounds of the general Formula (XIII): In particular the invention refers to a family of compounds that block the quorum sensing system of Gram-negative bacteria, a process for their manufacture, pharmaceutical compositions containing them and to their use for the treatment and prevention of microbial damages and diseases, in particular for diseases where there is an advantage in inhibiting quorum sensing regulated phenotypes of pathogens.
摘要:
The present invention relates to the use of compounds of the general Formula (XIII): wherein A7 is C═O, C═S, SO2, CH—OR13, C═NR12, or CH2—CHOR13; A8 is C(R14)2, O, S, or NR12; A9 is C═O, C═S, SO2, CH—OR13, C═NR12, or CH2—CHOR13; m is 0, or 1 q is 0, or 1 r is 0, or 1 R12 is H, CH3, CH2—CH3, C6H5, OCH3, OCH2—CH3, OH, or SH; R13 is H, CH3, or CH2—CH3; R14 is H, alkyl, alkoxy, OH, or SH;
摘要:
The present invention relates to the use of compounds of the general Formula (I): wherein in Formula (I), R is H, alkyl, cycloalkyl, aryl or heteroaryl; R1 is H, alkyl, cycloalkyl, aryl or heteroaryl; R2 is H, alkyl, cycloalkyl, aryl or heteroaryl; A1 and A2 each independently represent an optionally substituted C1-C20-alkyl group which may contain one or more group(s) Z, or a monocyclic or polycyclic optionally substituted aromatic or non-aromatic ring system which may contain one or more group(s) X, and in case of a polycyclic ring system, said system contains at least one aromatic ring; Z is selected from the group consisting of S, O, N, NR4, CO, CO2, CS, SO or SO2 X is selected from the group consisting of S, O, N, NR4, SO or SO2;
摘要:
The present invention relates to the use of compounds of the general Formula (I): wherein in Formula (I), R is H, alkyl, cycloalkyl, aryl or heteroaryl; R1 is H, alkyl, cycloalkyl, aryl or heteroaryl; R2 is H, alkyl, cycloalkyl, aryl or heteroaryl; A1 and A2 each independently represent an optionally substituted C1-C20-alkyl group which may contain one or more group(s) Z, or a monocyclic or polycyclic optionally substituted aromatic or non-aromatic ring system which may contain one or more group(s) X, and in case of a polycyclic ring system, said system contains at least one aromatic ring; Z is selected from the group consisting of S, O, N, NR4, CO, CO2, CS, SO or SO2 X is selected from the group consisting of S, O, N, NR4, SO or SO2;
摘要翻译:本发明涉及通式(I)的化合物的用途:其中在式(I)中,R为H,烷基,环烷基,芳基或杂芳基; R 1是H,烷基,环烷基,芳基或杂芳基; R 2是H,烷基,环烷基,芳基或杂芳基; A 1和A 2各自独立地表示任选取代的C 1 -C 20 -C 20 - 烷基,其可以含有 一个或多个Z基团或可以含有一个或多个基团X的单环或多环任选取代的芳族或非芳族环系统,并且在多环系统的情况下,所述体系包含至少一个 芳香环 Z选自S,O,N,NR 4,CO,CO 2,CS,SO或SO 2 X 选自S,O,N,NR 4,SO或SO 2;
摘要:
The present invention relates to the use of compounds of the general Formula (I): wherein in Formula (I), R is H, alkyl, cycloalkyl, aryl or heteroaryl; R1 is H, alkyl, cycloalkyl, aryl or heteroaryl; R2 is H, alkyl, cycloalkyl, aryl or heteroaryl; A1 and A2 each independently represent an optionally substituted C1-C20-alkyl group which may contain one or more group(s) Z, or a monocyclic or polycyclic optionally substituted aromatic or non-aromatic ring system which may contain one or more group(s) X, and in case of a polycyclic ring system, said system contains at least one aromatic ring; Z is selected from the group consisting of S, O, N, NR4, CO, CO2, CS, SO or SO2 X is selected from the group consisting of S, O, N, NR4, SO or SO2;
摘要翻译:本发明涉及通式(I)的化合物的用途:其中在式(I)中,R为H,烷基,环烷基,芳基或杂芳基; R 1是H,烷基,环烷基,芳基或杂芳基; R 2是H,烷基,环烷基,芳基或杂芳基; A 1和A 2各自独立地表示任选取代的C 1 -C 20 -C 20 - 烷基,其可以含有 一个或多个Z基团或可以含有一个或多个基团X的单环或多环任选取代的芳族或非芳族环系统,并且在多环系统的情况下,所述体系包含至少一个 芳香环 Z选自S,O,N,NR 4,CO,CO 2,CS,SO或SO 2 X 选自S,O,N,NR 4,SO或SO 2; SUB>
摘要:
The present invention relates to the use of compounds of the general Formula (I): wherein in Formula (I), R is H, alkyl, cycloalkyl, aryl or heteroaryl; R1 is H, alkyl, cycloalkyl, aryl or heteroaryl; R2 is H, alkyl, cycloalkyl, aryl or heteroaryl; A1 and A2 each independently represent an optionally substituted C1-C20-alkyl group which may contain one or more group(s) Z, or a monocyclic or polycyclic optionally substituted aromatic or non-aromatic ring system which may contain one or more group(s) X, and in case of a polycyclic ring system, said system contains at least one aromatic ring; Z is selected from the group consisting of S, O, N, NR4, CO, CO2, CS, SO or SO2 X is selected from the group consisting of S, O, N, NR4, SO or SO2;
摘要翻译:本发明涉及通式(I)的化合物的用途:其中在式(I)中,R为H,烷基,环烷基,芳基或杂芳基; R 1是H,烷基,环烷基,芳基或杂芳基; R 2是H,烷基,环烷基,芳基或杂芳基; A 1和A 2各自独立地表示任选取代的C 1 -C 20 -C 20 - 烷基,其可以含有 一个或多个Z基团或可以含有一个或多个基团X的单环或多环任选取代的芳族或非芳族环系统,并且在多环系统的情况下,所述系统包含至少一个 芳香环 Z选自S,O,N,NR 4,CO,CO 2,CS,SO或SO 2 X 选自S,O,N,NR 4,SO或SO 2;